Crinetics Pharmaceuticals
CRNX
CRNX
83 hedge funds and large institutions have $661M invested in Crinetics Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 47 increasing their positions, 13 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
4% more funds holding
Funds holding: 80 → 83 (+3)
5.91% less ownership
Funds ownership: 93.35% → 87.44% (-5.9%)
Holders
83
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$13.3M | |
| 2 | +$11.5M | |
| 3 | +$8.05M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$6.6M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.39M |
Top Sellers
| 1 | -$22.8M | |
| 2 | -$10.7M | |
| 3 | -$8.7M | |
| 4 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$4.15M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$3.69M |